MENU
BBH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

BBH stock forecast, quote, news & analysis

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® U... Show more

Category: #Health
BBH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BBH with price predictions
Jun 04, 2026

BBH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BBH turned positive on May 26, 2026. Looking at past instances where BBH's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 28, 2026. You may want to consider a long position or call options on BBH as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

BBH moved above its 50-day moving average on June 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBH advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

BBH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where BBH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BBH entered a downward trend on May 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), IQVIA Holdings (NYSE:IQV), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY), Exact Sciences Corp (NASDAQ:EXAS), Moderna (NASDAQ:MRNA), Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® U.S. Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Market Cap

The average market capitalization across the VanEck Biotech ETF ETF is 37.95B. The market cap for tickers in the group ranges from 1.66B to 188.67B. AMGN holds the highest valuation in this group at 188.67B. The lowest valued company is SRPT at 1.66B.

High and low price notable news

The average weekly price growth across all stocks in the VanEck Biotech ETF ETF was 10%. For the same ETF, the average monthly price growth was 20%, and the average quarterly price growth was 71%. ICLR experienced the highest price growth at 10%, while INSM experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the VanEck Biotech ETF ETF was 13%. For the same stocks of the ETF, the average monthly volume growth was -16% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 52
Price Growth Rating: 51
SMR Rating: 65
Profit Risk Rating: 74
Seasonality Score: 50 (-100 ... +100)
View a ticker or compare two or three
BBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
335 Madison Ave.19th FloorNew York
Phone
888-658-8287
Web
www.marketvectorsetfs.com
BBH's MACD Histogram crosses above signal line